Medchemfarma: Acció 2023
Medchemfarma has been beneficiary in the call for start-up capital grants for emerging technology companies for the year 2023, through Acció Program (https://accio.gencat.cat) to carry out the...
Discovery of novel drugs with improved potency and selectivity, administered in a way to allow high safety margins in order to treat respiratory disorders with high unmet medical need.
How do we achieve our vision?
Medchemfarma focused its internal resources on areas where the management team has deep expertise:
- Virtual drug design
- Medicinal Chemistry
- In Vitro Pharmacology
- Physico-chemical characterization of the compounds
- Intellectual Property